TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12175665

Group type: EXPERIMENTAL
Intervention: Enoxaparin (30 mg intravenous bolus and 1 mg/kg subcutaneous injections twice daily for 3-8 days)
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 496
Study: 9635630

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate 7.5 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate 3.75 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate (both doses)
Number of subjects: 100
Study: 7653805

Group type: EXPERIMENTAL
Intervention: Pancuronium 0.15 mg/kg
Number of subjects: 35
Study: 2654599

Group type: EXPERIMENTAL
Intervention: Ranitidine and pirenzepine (group 2)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ranitidine and placebo (group 1)
Number of subjects: 30
Study: 795494

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics
Number of subjects: 0
Study: 6113437

Group type: EXPERIMENTAL
Intervention: Nuclear magnetic resonance (NMR) imaging using an inversion recovery technique
Number of subjects: 22

Group type: COMPARATOR
Intervention: X-ray computed tomography (CT)
Number of subjects: 22
Study: 31241007

Group type: EXPERIMENTAL
Intervention: Combination of nano‐curcumin (80 mg) plus CoQ10 (300 mg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Nano‐curcumin (80 mg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CoQ10 (300 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (nano‐curcumin and CoQ10 placebo included oral paraffin oil)
Number of subjects: 100
Study: 29628182

Group type: EXPERIMENTAL
Intervention: Time In intervention (sensorimotor intervention combining biomechanical physiotherapeutic procedures and psychological strategies, 3h weekly sessions for 5 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 40
Study: 29302694

Group type: EXPERIMENTAL
Intervention: Active video game (binocular falling-blocks video game) played for 1 hour per day for 6 weeks.
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo video game played for 1 hour per day for 6 weeks.
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Active video game (binocular falling-blocks video game)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo video game
Number of subjects: 115
Study: 26752109

Group type: EXPERIMENTAL
Intervention: Ebastine (20 mg/day)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 24132766

Group type: COMPARATOR
Intervention: Software Package 1 (P1)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Software Package 2 (P2)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Software Package 3 (P3)
Number of subjects: 50
Study: 22305273

Group type: EXPERIMENTAL
Intervention: Regional citrate anticoagulation
Number of subjects: 10

Group type: COMPARATOR
Intervention: No anticoagulation
Number of subjects: 10
Study: 18635703

Group type: EXPERIMENTAL
Intervention: Org 28611 3-10 microg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Midazolam 0.1 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Org 28611 up to 1 microg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Org 28611 above 3 microg/kg
Number of subjects: 0
Study: 17224707

Group type: EXPERIMENTAL
Intervention: Haloperidol (2.5 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Olanzapine (10 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 15711670

Group type: EXPERIMENTAL
Intervention: Interferon (IFN) alfa 2b 3 million units 3 times per week plus ribavirin 1000-1200 mg orally per day for 48 weeks
Number of subjects: 62

Group type: COMPARATOR
Intervention: Interferon (IFN) alfa 2b alone
Number of subjects: 62
Study: 12109933

Group type: EXPERIMENTAL
Intervention: Bupropion SR
Number of subjects: 0
Study: 9740342

Group type: EXPERIMENTAL
Intervention: Intravenous diltiazem
Number of subjects: 121

Group type: COMPARATOR
Intervention: Intravenous nitroglycerin
Number of subjects: 121
Study: 7859421

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 50 mg/kg (single dose)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Cefaclor 40 mg/kg/day (10 days)
Number of subjects: 54
Study: 2816761

Group type: EXPERIMENTAL
Intervention: Theophylline (7 mg/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (10 mg)
Number of subjects: 10
Study: 128475

Group type: EXPERIMENTAL
Intervention: Locacorten (0.02%)-Vioform (3%) cream
Number of subjects: 430

Group type: COMPARATOR
Intervention: Vioform 3%
Number of subjects: 430

Group type: COMPARATOR
Intervention: Locacorten 0.02%
Number of subjects: 430

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 430
Study: 31607400

Group type: EXPERIMENTAL
Intervention: Piezosurgery (ultrasound motor tips)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Conventional rotary instrument
Number of subjects: 15
Study: 28606085

Group type: EXPERIMENTAL
Intervention: One4All strategy (intervention arm)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Standard of care (control arm)
Number of subjects: 180
Study: 24902962

Group type: EXPERIMENTAL
Intervention: Oral pioglitazone 30 mg daily for 10 weeks
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 23132643

Group type: EXPERIMENTAL
Intervention: Acidic saline (2.5 mL, pH 3.3)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Isotonic saline (2.5 mL, pH 6.0)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both interventions (acidic saline and isotonic saline)
Number of subjects: 18
Study: 21640683

Group type: EXPERIMENTAL
Intervention: Social determinants of health curriculum (intervention)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (prior year interns)
Number of subjects: 38
Study: 19787598

Group type: EXPERIMENTAL
Intervention: ICare
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: DCT
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: ORA (Goldmann-correlated IOP)
Number of subjects: 93

Group type: COMPARATOR
Intervention: GAT
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Patients' preference
Number of subjects: 93
Study: 16411869

Group type: EXPERIMENTAL
Intervention: Walking with a dog
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Interaction with the dog at home
Number of subjects: 13

Group type: COMPARATOR
Intervention: Walking without a dog
Number of subjects: 13
Study: 15235937

Group type: EXPERIMENTAL
Intervention: Local Anaesthesia (LA)
Number of subjects: 138

Group type: COMPARATOR
Intervention: General Anaesthesia (GA)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Regional Anaesthesia (RA)
Number of subjects: 138
Study: 11244441

Group type: EXPERIMENTAL
Intervention: Meningococcal polysaccharide (Men PS) vaccine, administered 8 months after BMT (early group; 22 patients)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Meningococcal polysaccharide (Men PS) vaccine, administered 20 months after BMT (late group; 22 patients)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Meningococcal polysaccharide (Men PS) vaccine, both early and late groups
Number of subjects: 44
Study: 9855434

Group type: EXPERIMENTAL
Intervention: Three-component acellular vaccine (3-5-12 schedule)
Number of subjects: 72898

Group type: EXPERIMENTAL
Intervention: Five-component vaccine (3-5-12 schedule)
Number of subjects: 72898

Group type: EXPERIMENTAL
Intervention: Whole-cell vaccine (3-5-12 schedule)
Number of subjects: 72898

Group type: COMPARATOR
Intervention: Multicomponent acellular vaccine (2-4-6 schedule)
Number of subjects: 72898

Group type: EXPERIMENTAL
Intervention: Delayed third dose (both schedules)
Number of subjects: 72898
Study: 8080071

Group type: EXPERIMENTAL
Intervention: recombinant interferon‐gamma (rIFN‐gamma)
Number of subjects: 212

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 212
Study: 2759604

Group type: EXPERIMENTAL
Intervention: Aylesbury spatula
Number of subjects: 4079

Group type: COMPARATOR
Intervention: Ayre spatula
Number of subjects: 4079
Study: 263815

Group type: EXPERIMENTAL
Intervention: Specific support for grief and encouragement of mourning during the first three months
Number of subjects: 200

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Specific support for grief and encouragement of mourning
Number of subjects: 200
Study: 31481010

Group type: EXPERIMENTAL
Intervention: Transforaminal epidural injection (TEI) with lidocaine and methylprednisolone acetate for L3 and below, and lidocaine with dexamethasone above L3.
Number of subjects: 142

Group type: COMPARATOR
Intervention: Standard oral pain medication.
Number of subjects: 142
Study: 28058505

Group type: EXPERIMENTAL
Intervention: six‐session couple‐separated psycho‐educational program
Number of subjects: 352

Group type: COMPARATOR
Intervention: usual care
Number of subjects: 352
Study: 25541084

Group type: EXPERIMENTAL
Intervention: External ventricular drain (EVD)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Intraparenchymal fiberoptic monitor (IPM)
Number of subjects: 122
Study: 24995271

Group type: EXPERIMENTAL
Intervention: Levofloxacin (500 mg), amoxicillin/clavulanate (875 mg/125 mg), and rabeprazole (20 mg) twice per day (LAcR)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Clarithromycin (500 mg), amoxicillin (1000 mg), and rabeprazole (20 mg) twice per day (CAR)
Number of subjects: 146
Study: 22766314

Group type: EXPERIMENTAL
Intervention: Pemetrexed 500 mg/m² intravenously day 1 with vitamin B12, folic acid, and dexamethasone
Number of subjects: 260

Group type: COMPARATOR
Intervention: Docetaxel 75 mg/m² intravenously day 1 with dexamethasone
Number of subjects: 260
Study: 18849664

Group type: EXPERIMENTAL
Intervention: DTwP/HB vaccine (Q‐Vac) administered alone (Group A)
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: DTwP and HB vaccines at separate sites (Group B)
Number of subjects: 447

Group type: COMPARATOR
Intervention: DTPw/HB vaccine (Tritanrix HB) (Group C)
Number of subjects: 447
Study: 17719471

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg for 6 weeks
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg for 6 weeks
Number of subjects: 20
Study: 15498107

Group type: EXPERIMENTAL
Intervention: Cell ELISA assay using 30-kD protein antigen
Number of subjects: 12
Study: 11427774

Group type: EXPERIMENTAL
Intervention: Dynamic physical training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dynamic physical training at 40-50% intensity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher intensity exercise
Number of subjects: 0
Study: 9250598

Group type: EXPERIMENTAL
Intervention: Exercise after a meal with suspected food ingestion
Number of subjects: 6

Group type: COMPARATOR
Intervention: Exercise after a meal without suspected food ingestion
Number of subjects: 6

Group type: COMPARATOR
Intervention: Suspected foods only
Number of subjects: 6
Study: 8483071

Group type: EXPERIMENTAL
Intervention: Wound instillation with 0.25% bupivacaine
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Caudal block with 0.25% bupivacaine
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70
Study: 3319721

Group type: EXPERIMENTAL
Intervention: Combination of grenz ray treatment and topical steroid
Number of subjects: 17

Group type: COMPARATOR
Intervention: Topical steroid alone
Number of subjects: 17
Study: 30630789

Group type: EXPERIMENTAL
Intervention: External application of Ji De Sheng She Yao and minimally invasive surgery
Number of subjects: 160

Group type: COMPARATOR
Intervention: Intravenous administration of cefmetazole and traditional excision
Number of subjects: 160
Study: 27565283

Group type: EXPERIMENTAL
Intervention: Ranking method (5 health states)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Ranking method (4 health states)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Ranking method (3 health states)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Paired comparison method
Number of subjects: 300
Study: 24368363

Group type: EXPERIMENTAL
Intervention: Intensive physiotherapy (usual care plus two additional 30-minute treatments each day)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Usual care (daily physiotherapy treatment, approximately 30 minutes)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Intensive physiotherapy
Number of subjects: 90
Study: 22439657

Group type: EXPERIMENTAL
Intervention: Enhanced expectancy group (provided with fabricated feedback about running efficiency every 2 min)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control group (not given feedback)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Enhanced expectancy group
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2
Study: 20857782

Group type: EXPERIMENTAL
Intervention: 1% silver sulphadiazine and 5% chlorhexidine dressing
Number of subjects: 38

Group type: COMPARATOR
Intervention: 5% chlorhexidine dressing alone
Number of subjects: 38
Study: 18235122

Group type: EXPERIMENTAL
Intervention: Standard-dose imatinib (400 mg daily)
Number of subjects: 746

Group type: EXPERIMENTAL
Intervention: High-dose imatinib (400 mg twice daily)
Number of subjects: 746

Group type: COMPARATOR
Intervention: Standard-dose imatinib (400 mg daily) followed by high-dose imatinib (400 mg twice daily) after progression
Number of subjects: 746
Study: 15653971

Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate (FP), 1,000 microg/d, then reduced to 200 microg/d (group 1)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Fixed dose of FP, 200 microg/d (group 2)
Number of subjects: 35
Study: 12608491

Group type: EXPERIMENTAL
Intervention: Alcoholic beer (8.5%) administered to reach a blood alcohol concentration of 40 mg/dl
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo beer (equivalent volume to alcoholic beer)
Number of subjects: 48
Study: 10440421

Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg once daily for 10 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 8909632

Group type: EXPERIMENTAL
Intervention: Level 1: General enhancement classroom intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Level 2: Intensive small-group sessions for at-risk children
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Level 3: One-year family relationship intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 1316060

Group type: EXPERIMENTAL
Intervention: 400 mg oral lomefloxacin 2-6 hours before surgery
Number of subjects: 63

Group type: COMPARATOR
Intervention: 1.5 g parenteral cefuroxime 30-90 minutes before surgery
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 400 mg oral lomefloxacin
Number of subjects: 63

Group type: COMPARATOR
Intervention: 1.5 g parenteral cefuroxime
Number of subjects: 63
Study: 3904259

Group type: EXPERIMENTAL
Intervention: Live, attenuated cold‐adapted influenza A vaccines (H1N1 and H3N2)
Number of subjects: 0
Study: 31554075

Group type: EXPERIMENTAL
Intervention: GanedenBC30 (1 × 10^9 colony-forming units)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 80
Study: 29769106

Group type: EXPERIMENTAL
Intervention: Peer-to-peer mentoring (MBA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Teacher-led (PBA)
Number of subjects: 20
Study: 26872892

Group type: EXPERIMENTAL
Intervention: Ixazomib administered after a high-fat meal
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ixazomib administered in fasted state
Number of subjects: 24
Study: 26169304

Group type: EXPERIMENTAL
Intervention: Thyroxine treatment
Number of subjects: 90
Study: 23315999

Group type: EXPERIMENTAL
Intervention: Brief eclectic psychotherapy for PTSD (successful treatment group, n = 10)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Brief eclectic psychotherapy for PTSD (unsuccessful treatment group, n = 10)
Number of subjects: 45
Study: 19756773

Group type: COMPARATOR
Intervention: Megestrol acetate (MA)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Megestrol acetate (MA) plus olanzapine (OLN)
Number of subjects: 80
Study: 17938943

Group type: EXPERIMENTAL
Intervention: Oral chlormadinone acetate
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intramuscular progesterone
Number of subjects: 40
Study: 16669976

Group type: EXPERIMENTAL
Intervention: Folic acid 5 mg/d (FA-5)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Folic acid 15 mg/d (FA-15)
Number of subjects: 17
Study: 12796671

Group type: EXPERIMENTAL
Intervention: 90 mg fluoxetine once weekly
Number of subjects: 80

Group type: COMPARATOR
Intervention: 20 mg fluoxetine daily
Number of subjects: 80
Study: 11370345

Group type: EXPERIMENTAL
Intervention: 40 mg/kg aqueous extract powder in 10 mL distilled water
Number of subjects: 20

Group type: COMPARATOR
Intervention: 10 mL distilled water (control)
Number of subjects: 20
Study: 8841891

Group type: EXPERIMENTAL
Intervention: Odontoson M plus an ionized irrigant solution
Number of subjects: 8

Group type: COMPARATOR
Intervention: Widman flap type surgical technique
Number of subjects: 8
Study: 1617924

Group type: EXPERIMENTAL
Intervention: Roxithromycin
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 142
Study: 6466047

Group type: EXPERIMENTAL
Intervention: 0.75 mL/kg of ethanol
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 1.1 mL/kg of ethanol
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control (FHN)
Number of subjects: 46
Study: 30944165

Group type: EXPERIMENTAL
Intervention: Concurrent focal noninvasive transcranial magnetic stimulation and electroencephalography
Number of subjects: 0

Group type: COMPARATOR
Intervention: Psychotherapy (best-validated treatment for PTSD)
Number of subjects: 0
Study: 29355727

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 77
Study: 27631861

Group type: EXPERIMENTAL
Intervention: Group therapy with reflective practice by therapists
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group therapy without consideration of group dynamics
Number of subjects: 0
Study: 24983187

Group type: EXPERIMENTAL
Intervention: 25 mg spironolactone (MRB group)
Number of subjects: 86

Group type: COMPARATOR
Intervention: 5 mg ramipril (RASB group)
Number of subjects: 86
Study: 22212211

Group type: EXPERIMENTAL
Intervention: Theory-based intervention delivered during three × one hour sessions over a three week period.
Number of subjects: 400

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 400
Study: 18547863

Group type: EXPERIMENTAL
Intervention: Cold-water immersion (COLD)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Contrast water immersion (CWI)
Number of subjects: 11

Group type: COMPARATOR
Intervention: No recovery treatment (control)
Number of subjects: 11
Study: 17983303

Group type: EXPERIMENTAL
Intervention: Stable communities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stable cities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Residential stability
Number of subjects: 0
Study: 16321740

Group type: EXPERIMENTAL
Intervention: 3 Tesla MRI using phased-array coils
Number of subjects: 5

Group type: COMPARATOR
Intervention: 1.5 Tesla MRI using phased-array coils
Number of subjects: 5
Study: 12461195

Group type: EXPERIMENTAL
Intervention: DISH (Depression Interview and Structured Hamilton)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: DISH administered by research nurses
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: DISH and BDI correlation
Number of subjects: 57
Study: 10091793

Group type: EXPERIMENTAL
Intervention: FAC (5-fluorouracil, doxorubicin, cyclophosphamide)
Number of subjects: 170

Group type: COMPARATOR
Intervention: NA (vinorelbine and doxorubicin)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: FAC
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: FAC and NA
Number of subjects: 170
Study: 7762527

Group type: EXPERIMENTAL
Intervention: Single dose of iodized oil A (490 mg I)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Split dose of iodized oil A (2 x 245 mg I)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single dose of iodized oil B (675 mg I)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Divided dose of oil A (2 x 245 mg I)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oil A (ethyl esters of iodized fatty acids)
Number of subjects: 0
Study: 2065322

Group type: EXPERIMENTAL
Intervention: Melanoma vaccine plus cyclophosphamide (300 mg/m2 i.v. 3 days prior to each vaccine immunization)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Melanoma vaccine alone
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Melanoma vaccine plus cyclophosphamide
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 45
Study: 6634945

Group type: EXPERIMENTAL
Intervention: Ultrasound treatment at 0.5 W/cm2
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Ultrasound treatment at 1.0 W/cm2
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Ultrasound treatment at 1.5 W/cm2
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo ultrasound treatment at 0.0 W/cm2
Number of subjects: 13
Study: 30054773

Group type: EXPERIMENTAL
Intervention: Fresh copra meal at 12.5% inclusion
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Fresh copra meal at 25% inclusion
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Stored copra meal at 12.5% inclusion
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Stored copra meal at 25% inclusion
Number of subjects: 280

Group type: COMPARATOR
Intervention: Corn-soybean meal diet (control)
Number of subjects: 280
Study: 29730344

Group type: EXPERIMENTAL
Intervention: Self-expandable transcatheter aortic valve replacement (TAVR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgical aortic valve replacement (SAVR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Comparison of TAVR to SAVR
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Probabilistic analysis (PA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sensitivity analysis with TAVR valve system cost at $17,397
Number of subjects: 0
Study: 26479024

Group type: EXPERIMENTAL
Intervention: Cycling training
Number of subjects: 16

Group type: COMPARATOR
Intervention: Running training
Number of subjects: 16